Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease

被引:0
|
作者
Jeong Woo Kim
Young-Sun Lee
Yang Shin Park
Baek-Hui Kim
Soo Yeon Lee
Jong Eun Yeon
Chang Hee Lee
机构
[1] Korea University Guro Hospital,Department of Radiology
[2] Korea University College of Medicine,Department of Radiology
[3] Korean Armed Forces Capital Hospital,Department of Internal Medicine
[4] Korea University Guro Hospital,Department of Pathology
[5] Korea University College of Medicine,undefined
[6] Korea University Guro Hospital,undefined
[7] Korea University College of Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Non-alcoholic steatohepatitis (NASH) is a complex disease consisting of various components including steatosis, lobular inflammation, and ballooning degeneration, with or without fibrosis. Therefore, it is difficult to diagnose NASH with only one imaging modality. This study was aimed to evaluate the feasibility of magnetic resonance imaging (MRI) for predicting NASH and to develop a non-invasive multiparametric MR index for the detection of NASH in non-alcoholic fatty liver disease (NAFLD) patients. This prospective study included 47 NAFLD patients who were scheduled to undergo or underwent ultrasound-guided liver biopsy within 2 months. Biopsy specimens were graded as NASH or non-NASH. All patients underwent non-enhanced MRI including MR spectroscopy (MRS), MR elastography (MRE), and T1 mapping. Diagnostic performances of MRS, MRE, and T1 mapping for grading steatosis, activity, and fibrosis were evaluated. A multiparametric MR index combining fat fraction (FF), liver stiffness (LS) value, and T1 relaxation time was developed using linear regression analysis. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of the newly devised MR index. Twenty NASH patients and 27 non-NASH patients were included. Using MRS, MRE, and T1 mapping, the mean areas under the curve (AUCs) for grading steatosis, fibrosis, and activity were 0.870, 0.951, and 0.664, respectively. The multiparametric MR index was determined as 0.037 × FF (%) + 1.4 × LS value (kPa) + 0.004 × T1 relaxation time (msec) −3.819. ROC curve analysis of the MR index revealed an AUC of 0.883. The cut-off value of 6 had a sensitivity of 80.0% and specificity of 85.2%. The multiparametric MR index combining FF, LS value, and T1 relaxation time showed high diagnostic performance for detecting NASH in NAFLD patients.
引用
收藏
相关论文
共 50 条
  • [1] Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
    Kim, Jeong Woo
    Lee, Young-Sun
    Park, Yang Shin
    Kim, Baek-Hui
    Lee, Soo Yeon
    Yeon, Jong Eun
    Lee, Chang Hee
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [2] Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease
    Kim, Jeong Woo
    Lee, Chang Hee
    Kim, Baek-Hui
    Lee, Young-Sun
    Hwang, Soon-Young
    Park, Bit Na
    Park, Yang Shin
    [J]. QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2022, 12 (03) : 1815 - 1829
  • [3] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Verna, Elizabeth C.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 211 - 223
  • [4] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [5] Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Dowman, J. K.
    Tomlinson, J. W.
    Newsome, P. N.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (05) : 525 - 540
  • [6] Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential
    Bedossa, Pierre
    [J]. LIVER INTERNATIONAL, 2018, 38 : 64 - 66
  • [7] Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Tincopa, Monica A.
    Loomba, Rohit
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (07): : 660 - 670
  • [8] Sex difference in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Tomiya, Tomoaki
    [J]. HEPATOLOGY RESEARCH, 2010, 40 (01) : 108 - 110
  • [9] Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis - NASH
    Keller, KM
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (08) : 864 - 869
  • [10] Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Pittaras, Andreas
    Faselis, Charles
    Narayan, Puneet
    Kokkinos, Peter
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (03) : 239 - 245